Clinical trials recruiting for Biliary Tract Cancer (BTC)
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| Colorado | 2 |
| Massachusetts | 2 |
| North Carolina | 2 |
| Texas | 2 |
| Wisconsin | 2 |
| Indiana | 1 |
| Iowa | 1 |
| Kentucky | 1 |
| New Jersey | 1 |
| New York | 1 |
| Pennsylvania | 1 |
Top cities
Self-screener
Recruiting trials
- In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers
- Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
- Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
- YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies
Related conditions
Trials recruiting for Biliary Tract Cancer (BTC) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Biliary Tract Cancer (BTC) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.